Delivery Order SPE2DB20D3505-SPE2DB22FT7J0
- Not listed
- This federal contract award, valued at $11,255.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2025 and is a firm fixed-price contract. The award is not designated as a set-aside contract, indicating open competition....
- This federal contract award, valued at $106,555.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) and has a Firm Fixed Price pricing type. The contract covers the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a completion date of May 1, 2024. This award was made through full and open competition, with no set-aside...
- This federal contract award, valued at $31,414.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The award is a delivery order to support the supply of MENVEO A-C-Y-W-135-DIP VIAL KTS, a critical medical product. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,724.28, is a delivery order for 4559084703 - MENVEO A-C-Y-W-135-DIP VIAL KTS. The award is not associated with a set-aside program and has an ultimate completion date of November 15, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award, valued at $18,353.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with a performance period ending on August 11, 2023. The contract has a Firm Fixed Price pricing type and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a for-profit...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $12,177.00 for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of March 13, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award is for the delivery of Menveo 1 vial-A-C-Y-W-135-DIP 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $112,034.64, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a firm fixed price pricing type and an ultimate completion date of August 21, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $18,265.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a completion date of September 13, 2024. This is a firm-fixed-price delivery order contract, which indicates that Amerisourcebergen will provide the specified medical product at a predetermined price. Amerisourcebergen is a major...
- This federal contract award, valued at $21,763.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS)S, which are likely vaccines or other medical supplies. The contract is a Firm Fixed Price Delivery Order with a performance period ending on May 20, 2025. Amerisourcebergen Drug Corp is the prime contractor and there is no...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $3,769.68 firm fixed-price delivery order is for the provision of 4554306395 MENVEO A-C-Y-W-135-DIP VIAL KTS, a pharmaceutical product. The contract has an ultimate completion date of August 4, 2021. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT7J0Delivery Order
This federal contract award, valued at $11,720.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENVEO A-C-Y-W-135-DIP VIAL KTS, a pharmaceutical product, with a completion date of May 2, 2022. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation mentioned. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also does business as Amerisourcebergen. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award is likely part of the broader medical commodities procurement efforts of the DLA to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 4/29/22 |